$2.32T
Total marketcap
$107.82B
Total volume
BTC 49.94%     ETH 15.50%
Dominance

Balchem Corporation BL9B.F Stock

138.7 EUR {{ price }} -0.143986% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
4.48B EUR
LOW - HIGH [24H]
138.7 - 138.7 EUR
VOLUME [24H]
35 EUR
{{ volume }}
P/E Ratio
44.45
Earnings per share
3.12 EUR

Balchem Corporation Price Chart

Balchem Corporation BL9B.F Financial and Trading Overview

Balchem Corporation stock price 138.7 EUR
Previous Close 122.9 EUR
Open 122.8 EUR
Bid 122.7 EUR x 20000
Ask 126.2 EUR x 20000
Day's Range 122.7 - 122.8 EUR
52 Week Range 107.3 - 142.4 EUR
Volume 4 EUR
Avg. Volume 6 EUR
Market Cap 3.96B EUR
Beta (5Y Monthly) 0.703873
PE Ratio (TTM) 43.35689
EPS (TTM) 3.12 EUR
Forward Dividend & Yield 0.66 (0.53%)
Ex-Dividend Date December 23, 2022
1y Target Est 150.75 EUR

BL9B.F Valuation Measures

Enterprise Value 4.35B EUR
Trailing P/E 43.35689
Forward P/E 29.709442
PEG Ratio (5 yr expected) 1.63
Price/Sales (ttm) 4.185087
Price/Book (mrq) 4.062107
Enterprise Value/Revenue 4.598
Enterprise Value/EBITDA 22.182

Trading Information

Balchem Corporation Stock Price History

Beta (5Y Monthly) 0.703873
52-Week Change 16.30%
S&P500 52-Week Change 20.43%
52 Week High 142.4 EUR
52 Week Low 107.3 EUR
50-Day Moving Average 116.13 EUR
200-Day Moving Average 123.2 EUR

BL9B.F Share Statistics

Avg. Volume (3 month) 6 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 32.23M
Float 31.94M
Short Ratio N/A
% Held by Insiders 0.93%
% Held by Institutions 91.63%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.71
Trailing Annual Dividend Yield 0.57%
5 Year Average Dividend Yield 48.00%
Payout Ratio 0.23200001
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 10.47%
Operating Margin (ttm) 15.10%
Gross Margin 29.82%
EBITDA Margin 20.72%

Management Effectiveness

Return on Assets (ttm) 6.32%
Return on Equity (ttm) 10.73%

Income Statement

Revenue (ttm) 946.03M EUR
Revenue Per Share (ttm) 29.54 EUR
Quarterly Revenue Growth (yoy) 1.60%
Gross Profit (ttm) 280.45M EUR
EBITDA 196.09M EUR
Net Income Avi to Common (ttm) 99.15M EUR
Diluted EPS (ttm) 2.83
Quarterly Earnings Growth (yoy) -21.50%

Balance Sheet

Total Cash (mrq) 60.93M EUR
Total Cash Per Share (mrq) 1.89 EUR
Total Debt (mrq) 449.88M EUR
Total Debt/Equity (mrq) 46.22 EUR
Current Ratio (mrq) 2.88
Book Value Per Share (mrq) 30.206

Cash Flow Statement

Operating Cash Flow (ttm) 166.35M EUR
Levered Free Cash Flow (ttm) 69.59M EUR

Profile of Balchem Corporation

Country Germany
State NJ
City Montvale
Address 5 Paragon Drive
ZIP 07645
Phone 845 326 5600
Website https://www.balchem.com
Industry Specialty Chemicals
Sector(s) Basic Materials
Full Time Employees 1331

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Q&A For Balchem Corporation Stock

What is a current BL9B.F stock price?

Balchem Corporation BL9B.F stock price today per share is 138.7 EUR.

How to purchase Balchem Corporation stock?

You can buy BL9B.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Balchem Corporation?

The stock symbol or ticker of Balchem Corporation is BL9B.F.

Which industry does the Balchem Corporation company belong to?

The Balchem Corporation industry is Specialty Chemicals.

How many shares does Balchem Corporation have in circulation?

The max supply of Balchem Corporation shares is 32.27M.

What is Balchem Corporation Price to Earnings Ratio (PE Ratio)?

Balchem Corporation PE Ratio is 44.45512800 now.

What was Balchem Corporation earnings per share over the trailing 12 months (TTM)?

Balchem Corporation EPS is 3.12 EUR over the trailing 12 months.

Which sector does the Balchem Corporation company belong to?

The Balchem Corporation sector is Basic Materials.